Monday, January 25, 2021

Moderna and Pfizer-BioNTech reconsider their battle plans after a variant proves more challenging.


By BY DENISE GRADY from NYT World https://nyti.ms/36eynw5 New York Times
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)